Anti-beta1AR antibodies in dilated cardiomyopathy: are these a new class of receptor agonists?
Hébert
Terence E
TE
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000378:metabolism; D000818:Animals; D001323:Autoantibodies / Q000502:physiology*; D002311:Cardiomyopathy, Dilated / Q000276:immunology* / Q000378:metabolism; D006333:Heart Failure / Q000201:enzymology / Q000276:immunology; D006801:Humans; D020935:MAP Kinase Signaling System; D051379:Mice; D009206:Myocardium / Q000201:enzymology / Q000276:immunology*; D018342:Receptors, Adrenergic, beta-1 / Q000276:immunology*
D000319:Adrenergic beta-Antagonists; D001323:Autoantibodies; D018342:Receptors, Adrenergic, beta-1